Ontario company receives first-ever Health Canada approval to make cannabis pharmaceuticals

1w
1m read
Summary

Burlington’s EmpowerPharm, a new clinical-stage, Canadian-owned drug company, made the announcement this week. An Ontario pharmaceutical company claims to be the first in the country to have a certified good manufacturing practices (GMP) facility that will be wholly dedicated to making CBD tablets and capsules. Pharmaceutical company claims to have developed a cannabis treatment for coronavirus symptoms While the company was already in possession of numerous cannabis-related certifications, including a Cannabis Drug Licence, a Standard Processing Licence and a Cannabis Research Licence, it reports that its Drug Establishment Licence (DEL) certifies EmpowerPharm as compliant with GMP standards. Cannabidiol (CBD) is a psychoactive, but non-intoxicating, compound derived from the cannabis plant that has exploded in popularity over the past few years. More women switch out pharmaceuticals for medical cannabis CBD as medicine — How much do we know so far?

Article Preview

An Ontario pharmaceutical company claims to be the first in the country to have a certified good manufacturing practices (GMP) facility that will be wholly dedicated to making CBD tablets and capsules.

Burlington’s EmpowerPharm, a new clinical-stage, Canadian-owned drug company, made the announcement this week.

More women...

Read the full article @ The Growth Op